Literature DB >> 23371015

Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy.

Udayakumar Navaneethan1, Ramprasad Jegadeesan, Norma G Gutierrez, Preethi G K Venkatesh, Andrea V Arrossi, Ana E Bennett, Tarun Rai, Feza H Remzi, Bo Shen, Ravi P Kiran.   

Abstract

BACKGROUND: The significance of backwash ileitis (BWI) relating to the risk of colon neoplasia in ulcerative colitis (UC) patients is controversial. AIM: We investigated the association between BWI and the presence of colon neoplasia in the colectomy specimen.
METHODS: From 4,198 UC patients in a prospectively maintained pouch database from 1983 to 2011, patients with extensive colitis and BWI (n = 178) in proctocolectomy were compared with 537 controls [extensive colitis (n = 385) and left-sided colitis (n = 152)] without ileal inflammation.
RESULTS: Colon neoplasia (colon dysplasia and/or colon cancer) was seen in 32 (18 %) patients with BWI in contrast to 45 (11.7 %) with extensive colitis and 13 (8.6 %) with left-sided colitis alone (p = 0.03). Of those with BWI, colon cancer was seen in 10 patients (5.6 %), while low grade and high grade dysplasia were seen in 7 (3.9 %) and 15 (8.4 %) patients respectively. On multivariate analysis, the presence of BWI with extensive colitis [odds ratio (OR) = 3.53; 95 % confidence interval (CI) 1.01-12.30, p = 0.04], presence of primary sclerosing cholangitis (PSC) (OR = 5.79, 95 % CI 1.92-17.40, p = 0.002) and moderate to severe disease activity at UC diagnosis (OR 4.29, 95 % CI 2.06-9.01, p < 0.001) were associated with an increased risk for identifying any colon neoplasia. For colon cancer, the presence of PSC (OR = 11.30, 95 % CI 1.54-80.9, p = 0.01) was the only factor independently associated with an increased risk.
CONCLUSIONS: The presence of BWI with extensive colitis was associated with the risk of identifying colon neoplasia but not cancer alone in the proctocolectomy specimen.

Entities:  

Mesh:

Year:  2013        PMID: 23371015     DOI: 10.1007/s10620-013-2571-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy.

Authors:  Andrea V Arrossi; Yehuda Kariv; Mary P Bronner; Jeffrey Hammel; Feza H Remzi; Victor W Fazio; John R Goldblum
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

2.  Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.

Authors:  U A Heuschen; U Hinz; E H Allemeyer; J Stern; M Lucas; F Autschbach; C Herfarth; G Heuschen
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis.

Authors:  S Gustavsson; L H Weiland; K A Kelly
Journal:  Dis Colon Rectum       Date:  1987-01       Impact factor: 4.585

Review 4.  Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

5.  5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.

Authors:  Charles N Bernstein; Zoann Nugent; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

6.  Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis.

Authors:  Henry Haskell; Charles W Andrews; Sarathchandra I Reddy; Klea Dendrinos; Francis A Farraye; Arthur F Stucchi; James M Becker; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2005-11       Impact factor: 6.394

7.  5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.

Authors:  Geoffrey C Nguyen; Aliya Gulamhusein; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2012-07-03       Impact factor: 10.864

8.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 9.  Role of bile acids in colorectal carcinogenesis.

Authors:  F M Nagengast; M J Grubben; I P van Munster
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

10.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

Authors:  Roopali Bansal Gupta; Noam Harpaz; Steven Itzkowitz; Sabera Hossain; Sierra Matula; Asher Kornbluth; Carol Bodian; Thomas Ullman
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

View more
  2 in total

Review 1.  Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.

Authors:  Deepa T Patil; Robert D Odze
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

Review 2.  Colonoscopic evaluation in ulcerative colitis.

Authors:  Elizabeth R Paine
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.